subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: cancer


subject: UMLS:C0360094

object_name: neoplasm

tested_intervention: yes


subject: CHEBI:6538

subject_name: Loratadine

object_name: plasma cell myeloma


subject: CHEBI:7772

subject_name: omeprazole

object_name: Helicobacter pylori [H. pylori] infection in conditions classified elsewhere and of unspecified site

tested_intervention: unsure


subject: CHEBI:7772

object_name: iron deficiency anemia


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:3732


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: CHEBI:51254


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:78825

subject_name: Avutometinib

object_name: Adult Solid Neoplasm


subject: CHEBI:78825

object_name: Childhood Solid Neoplasm


subject: CHEBI:78825

object_name: Solid Neoplasm


subject: CHEBI:78825

object_name: refractory malignant neoplasm


subject: CHEBI:78825

object_name: Adult Central Nervous System Neoplasm


subject: CHEBI:78825

object_name: central nervous system cancer


subject: CHEBI:78825

object_name: Childhood Central Nervous System Neoplasm


subject: CHEBI:78825

object_name: Solid carcinoma


subject: CHEBI:78825

object_name: neurofibromatosis 1


subject: CHEBI:78825

object_name: neurofibromatosis type 1


subject: CHEBI:78825

object_name: central nervous system neoplasm


subject: CHEBI:78825

object_name: ERK Family Gene Mutation


subject: CHEBI:78825

object_name: primary brain neoplasm


subject: CHEBI:78825

object_name: brain cancer


subject: CHEBI:78825

object_name: plexiform neurofibroma


subject: CHEBI:78825

object_name: low grade glioma


subject: CHEBI:78825

object_name: Childhood Neuroblastoma


subject: CHEBI:78825

object_name: neuroblastoma


subject: UNII:01KC87F8FE

object_name: glioma


subject: UNII:01KC87F8FE

object_name: malignant glioma


subject: UNII:01KC87F8FE

object_name: adult oligodendroglioma


subject: UNII:01KC87F8FE

object_name: oligodendroglioma


subject: UNII:01KC87F8FE

object_name: childhood oligodendroglioma


subject: UNII:01KC87F8FE

object_name: Childhood Oligoastrocytoma


subject: UNII:01KC87F8FE

object_name: oligoastrocytoma


subject: UNII:01KC87F8FE

object_name: Childhood Astrocytoma


subject: UNII:01KC87F8FE

object_name: astrocytic tumor


subject: UNII:01KC87F8FE

object_name: astrocytoma


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin

object_name: Premature infant


subject: PUBCHEM.COMPOUND:126456119

object_name: Premature birth


subject: PR:000009978

subject_name: lactotransferrin


subject: PR:000009978


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UMLS:C0022942


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: UniProtKB:Q8TCD2


subject: UMLS:C0062527

subject_name: Engerix-B

object_name: Chronic uremia


subject: UNII:06P3KLK2J8

subject_name: Glofitamab

object_name: large B-cell lymphoma


subject: UMLS:C4725069

subject_name: glofitamab


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UMLS:C4727698

subject_name: Miptenalimab

object_name: Neoplasm Metastasis


subject: UMLS:C4287781


subject: CHEBI:25357

subject_name: mitomycin

object_name: Stomach cancer


subject: CHEBI:25357

object_name: gastric cancer


subject: CHEBI:31521

subject_name: Doxifluridine


subject: CHEBI:31521


subject: CHEBI:17924

subject_name: Sorbitol

object_name: HIV infection


subject: CHEBI:8805

subject_name: Repaglinide

object_name: Parkinson disease


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: Infection of musculoskeletal system


subject: CHEBI:59594

subject_name: Colesevelam

object_name: Early Stage Breast Carcinoma


subject: CHEBI:59594

object_name: Hormone Receptor Positive


subject: CHEBI:59594

object_name: HER2 positive breast carcinoma


subject: CHEBI:6532

subject_name: Loperamide


subject: CHEBI:6532


subject: CHEBI:61397

subject_name: Neratinib


subject: CHEBI:64312

subject_name: Memantine

object_name: complete trisomy 21


subject: CHEBI:64312

object_name: Down syndrome


subject: CHEBI:174615

object_name: adult acute lymphoblastic leukemia


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UNII:NZW2BOW35N

subject_name: ELINZANETANT

object_name: Menopause present (finding)


subject: UNII:NZW2BOW35N

object_name: Menopause


subject: UNII:NZW2BOW35N

object_name: Middle Insomnia


subject: DRUGBANK:DB18968

subject_name: Elinzanetant


subject: DRUGBANK:DB18968


subject: DRUGBANK:DB18968


subject: UMLS:C5787214


subject: UMLS:C5787214


subject: UMLS:C5787214


subject: UMLS:C5446501

subject_name: Anti-Lewis B/Lewis Y Monoclonal Antibody GNX102

object_name: Childhood Solid Neoplasm


subject: UMLS:C5446501

object_name: Adult Solid Neoplasm


subject: UMLS:C5446501

object_name: Solid Neoplasm


subject: UMLS:C5446501

object_name: Advanced cancer


subject: UMLS:C5446501

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5446501

object_name: Embolism, Tumor


subject: UMLS:C5446501

object_name: Neoplasm Metastasis


subject: UMLS:C5446501

object_name: Unresectable Solid Neoplasm


subject: UNII:N1GRK350ZM

subject_name: Zabedosertib

object_name: atopic eczema


subject: UMLS:C5772966


subject: UMLS:C5669600

subject_name: Ivonescimab

object_name: Childhood Breast Carcinoma


subject: UMLS:C5669600

object_name: breast carcinoma


subject: UMLS:C5669600

object_name: breast cancer


subject: UMLS:C4733689

subject_name: Vulinacimab


subject: UMLS:C1174389

object_name: head and neck neoplasm


subject: CHEBI:32139

object_name: Pulmonary Ventilation


subject: CHEBI:231087

subject_name: Trilaciclib

object_name: carcinoma of esophagus


subject: CHEBI:231087

object_name: esophageal cancer


subject: CHEBI:231087

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:231087

object_name: neoplasm of esophagus


subject: CHEBI:90912

subject_name: rolapitant hydrochloride (anhydrous)

object_name: Locally Advanced Sarcoma


subject: PUBCHEM.COMPOUND:44215723

subject_name: Rolapitant


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: mild neurocognitive disorder


subject: CHEBI:36005

object_name: mild cognitive impairment


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: PUBCHEM.COMPOUND:145948323

subject_name: ELIGLUSTAT TARTRATE

object_name: Gaucher disease type I


subject: PUBCHEM.COMPOUND:11531537

subject_name: Eliglustat


subject: MESH:C000715128

subject_name: abidol


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b


subject: UMLS:C0751598

subject_name: Alferon


subject: CHEBI:26536

subject_name: retinoic acid

object_name: Hypercholesterolemia


subject: CHEBI:28870


subject: CHEBI:15367

subject_name: Tretinoin


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:6067

subject_name: Isotretinoin


subject: UNII:71ANL51TLA

subject_name: Menaquinone 6

object_name: Vascular calcification


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: PUBCHEM.COMPOUND:44278770

subject_name: SANDOSTATIN

object_name: acromegaly


subject: PUBCHEM.COMPOUND:44278770

object_name: Acral overgrowth


subject: UNII:QMS40680K6

subject_name: Palifermin

object_name: non-Hodgkin lymphoma


subject: CHEBI:17087

subject_name: ketone

object_name: Concussive injury


subject: CHEBI:17087

object_name: concussion


subject: CHEBI:17087

object_name: Mild Traumatic Brain Injury


subject: CHEBI:17087

object_name: Concussion, Severe


subject: CHEBI:17087

object_name: Sports injuries in children


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Advanced Liposarcoma


subject: CHEBI:231005

object_name: Advanced Leiomyosarcoma


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: PUBCHEM.COMPOUND:139350422

subject_name: Zanzalintinib


subject: PUBCHEM.COMPOUND:139350422


subject: UNII:KC2JC2ZA04

subject_name: ZANZALINTINIB


subject: UNII:KC2JC2ZA04


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: BCLC Stage C Hepatocellular Carcinoma


subject: CHEBI:72317

object_name: BCLC Stage B Hepatocellular Carcinoma


subject: CHEBI:43871

subject_name: Fasudil

object_name: retinal vein occlusion


subject: UMLS:C1508862

subject_name: INJECTION, BEVACIZUMAB, 10 MG, Administered


subject: UMLS:C2729368

subject_name: INJECTION, BEVACIZUMAB, 0.25 MG, Administered


subject: UMLS:C5203354

subject_name: Bevacizumab Liquid Injection


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:91368

subject_name: Enzastaurin

object_name: T-Cell Lymphoma


subject: CHEBI:91368

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:91368

object_name: B-cell non-Hodgkin lymphoma


subject: CHEBI:91368

object_name: B-cell neoplasm


subject: UMLS:C5544272


subject: CHEBI:39867

subject_name: Valproic acid

object_name: scleroderma


subject: CHEBI:39867

object_name: systemic sclerosis


subject: CHEBI:59902

subject_name: ENTECAVIR

object_name: non-Hodgkin lymphoma


subject: CHEBI:473990

subject_name: Entecavir


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib

object_name: adult lymphoma


subject: UNII:SQ8A3S5101

object_name: lymphoma


subject: UNII:SQ8A3S5101

object_name: pediatric lymphoma


subject: CHEBI:39462

subject_name: pilocarpine

object_name: ocular hypertension


subject: CHEBI:39462

object_name: open-angle glaucoma


subject: CHEBI:8207

subject_name: Pilocarpine


subject: CHEBI:8207


subject: CHEBI:6504

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:6504

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:6504

object_name: adult acute monocytic leukemia


subject: CHEBI:6504

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:6504

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:6504

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:6504

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:6504

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:6504

object_name: Adult Erythroleukemia


subject: CHEBI:15367

subject_name: Tretinoin

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:15367

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:15367


subject: CHEBI:15367

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:15367

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:15367

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:15367


subject: CHEBI:15367


subject: CHEBI:15367


subject: CHEBI:15367


subject: CHEBI:15367


subject: CHEBI:15367


subject: CHEBI:15367


subject: CHEBI:15367


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: cancer


subject: CHEBI:70746

object_name: Deep venous thrombosis


subject: CHEBI:70746

object_name: pulmonary embolism


subject: CHEBI:70746

object_name: Blood Clot


subject: CHEBI:70746

object_name: thrombosis


subject: CHEBI:70746

object_name: Thrombus


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:151315

subject_name: Heparin


subject: GTOPDB:6803

subject_name: dalteparin


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate


subject: CHEBI:85974


subject: CHEBI:85974


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: PUBCHEM.COMPOUND:11635624


subject: PUBCHEM.COMPOUND:11635624


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: PUBCHEM.COMPOUND:52943456

subject_name: FONDAPARINUX


subject: PUBCHEM.COMPOUND:52943456

object_name: neoplasm


subject: PUBCHEM.COMPOUND:52943456


subject: PUBCHEM.COMPOUND:52943456


subject: PUBCHEM.COMPOUND:52943456


subject: PUBCHEM.COMPOUND:52943456


subject: CHEBI:61033

subject_name: Fondaparinux


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:10033


subject: MESH:D017778

subject_name: Vaccines, Combined

object_name: diphtheria


subject: MESH:D017778

object_name: pertussis


subject: MESH:D017778

object_name: tetanus


subject: CHEBI:37807

subject_name: ethyl group

object_name: alcohol; harmful use


subject: CHEBI:62801

subject_name: ethyl


subject: UNII:0661V34NTV

object_name: Lewy Bodies


subject: PUBCHEM.COMPOUND:58827053

subject_name: Osilodrostat

object_name: adrenocortical insufficiency


subject: PUBCHEM.COMPOUND:58827053

object_name: Adrenal Insufficiency, CTCAE


subject: PUBCHEM.COMPOUND:58827053

object_name: endogenous Cushing syndrome


subject: MESH:C576871

subject_name: delta inulin

object_name: Ant sting


subject: UMLS:C2607428

object_name: Inflammation


subject: UMLS:C2607428

object_name: cataract


subject: UMLS:C2607428

object_name: Cataract, CTCAE 3.0


subject: UMLS:C2607428

object_name: Cataract, CTCAE 5.0


subject: UMLS:C2607428

object_name: cataract on exam (physical finding)


subject: UMLS:C3896822

object_name: anemia


subject: UMLS:C3896822

object_name: Anemia, CTCAE


subject: CHEBI:136051

subject_name: Lusutrombopag

object_name: thrombocytopenia due to immune destruction


subject: GTOPDB:6788

subject_name: drotrecogin alfa

object_name: Infection


subject: GTOPDB:6788

object_name: infectious disease


subject: GTOPDB:6788

object_name: Adverse Event Associated with Infection


subject: GTOPDB:6788

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C1170000


subject: UMLS:C1170000


subject: UMLS:C1170000


subject: UMLS:C1170000


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:31198

subject_name: Ambroxol hydrochloride

object_name: Lewy Bodies


subject: UNII:CC995ZMV90

subject_name: AMBROXOL HYDROCHLORIDE


subject: CHEBI:135590

subject_name: Ambroxol


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Surgical procedure finding


subject: CHEBI:194548

subject_name: Racepinephrine


subject: UMLS:C0962969

subject_name: RAD 001

object_name: neuroendocrine carcinoma


subject: UMLS:C0962969

object_name: pancreatic endocrine carcinoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:231679

subject_name: ipilimumab

object_name: ovarian neoplasm


subject: CHEBI:231679

object_name: Malignant neoplasm of female breast


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: non-Hodgkin lymphoma


subject: UMLS:C5417806

subject_name: Recombinant Bacterial Minicells VAX014

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Ischemic stroke


subject: UMLS:C0445115

object_name: intracerebral hemorrhage


subject: MESH:D000077331

subject_name: Ringer's Solution


subject: MESH:D000077331


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:22652

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:22652

object_name: Pancreatic carcinoma stage III


subject: CHEBI:22652

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:22652

object_name: pancreatic adenocarcinoma


subject: CHEBI:22652

object_name: Pancreatic carcinoma non-resectable


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881


subject: CHEBI:8988


subject: CHEBI:15640

subject_name: Leucovorin


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: PUBCHEM.COMPOUND:16683012

subject_name: Sodium stibogluconate

object_name: leishmaniasis


subject: PUBCHEM.COMPOUND:16683013

subject_name: Stibogluconate


subject: CHEBI:28148


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Colon Neoplasm


subject: CHEBI:4026

object_name: thymus neoplasm


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367

object_name: gastric neoplasm


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:132922

object_name: urinary tract infection


subject: CHEBI:132922

object_name: bacterial urinary tract infection


subject: CHEBI:132922

object_name: Urinary Tract Infection, CTCAE


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: Disorder of transplanted kidney


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C5454976

object_name: Hepatic impairment


subject: CHEBI:170007

subject_name: Nirmatrelvir


subject: CHEBI:60791

subject_name: Xylocard

object_name: Postoperative Pain, Chronic


subject: CHEBI:6456

subject_name: Lidocaine


subject: UMLS:C0086466

subject_name: Injectables


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: Solid Neoplasm


subject: CHEBI:31547

subject_name: Eplerenone

object_name: hypoglycemia


subject: CHEBI:31547

object_name: Blood glucose below reference range (finding)


subject: CHEBI:31547

object_name: Hypoglycemia, CTCAE


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: osteogenesis imperfecta


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:229220

subject_name: Repotrectinib

object_name: non-small cell lung carcinoma


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: coronary artery disorder


subject: CHEBI:28787

object_name: coronary atherosclerosis


subject: UMLS:C0935963

object_name: lung cancer


subject: UMLS:C0935963

object_name: lung neoplasm


subject: UMLS:C0935963

object_name: lung carcinoma


subject: UNII:KXQ762CQTH

object_name: ovarian cancer


subject: UNII:KXQ762CQTH

object_name: ovarian neoplasm


subject: UNII:KXQ762CQTH

object_name: ovarian carcinoma


subject: UNII:KXQ762CQTH

object_name: peritoneum cancer


subject: UNII:J6U9WP10T7


subject: UNII:J6U9WP10T7


subject: UNII:J6U9WP10T7


subject: UNII:J6U9WP10T7


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: Richter syndrome


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: PUBCHEM.COMPOUND:500216

subject_name: Bakuchiol

object_name: Postinflammatory hyperpigmentation


subject: CHEBI:9352

subject_name: Sulindac

object_name: fibromatosis


subject: CHEBI:9352

object_name: desmoid tumor


subject: CHEBI:9352

object_name: Desmoid tumor


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:41774


subject: CHEBI:41774


subject: UMLS:C5666845

subject_name: Aurora A Kinase Inhibitor VIC-1911


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: lung adenocarcinoma


subject: CHEBI:68534

object_name: breast neoplasm


subject: CHEBI:68534

object_name: adult liposarcoma


subject: CHEBI:68534

object_name: liposarcoma


subject: CHEBI:68534

object_name: pediatric liposarcoma


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413

object_name: prostate carcinoma


subject: CHEBI:6413

object_name: prostate cancer


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: UMLS:C5446887

subject_name: CDK4 Inhibitor PF-07220060


subject: UMLS:C5446887


subject: UMLS:C5446887


subject: UMLS:C5446887


subject: UMLS:C5446887


subject: UMLS:C5446887


subject: UMLS:C5446887


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: colorectal cancer


subject: CHEBI:81579

object_name: colorectal carcinoma


subject: CHEBI:81579

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Mantle cell lymphoma stage I


subject: CHEBI:31355

object_name: Mantle cell lymphoma stage III


subject: CHEBI:31355

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:31355

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:31355

object_name: Cutaneous T-cell lymphoma stage I


subject: CHEBI:31355

object_name: Cutaneous T-cell lymphoma stage II


subject: CHEBI:31355

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:31355

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:31355

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:31355

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: CHEBI:31355

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: CHEBI:31355

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:31355

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:31355

object_name: anaplastic large cell lymphoma


subject: CHEBI:31355

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:31355

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:31355

object_name: Mycosis fungoides/Sezary syndrome stage II


subject: CHEBI:31355

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:31355

object_name: Mycosis fungoides/Sezary syndrome stage I


subject: CHEBI:4911

subject_name: Etoposide

object_name: Mantle cell lymphoma stage I


subject: CHEBI:4911

object_name: Mantle cell lymphoma stage III


subject: CHEBI:4911

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:4911

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:4911

object_name: Cutaneous T-cell lymphoma stage I


subject: CHEBI:4911

object_name: Cutaneous T-cell lymphoma stage II


subject: CHEBI:4911

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:4911

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:4911

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:4911

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: CHEBI:4911

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: CHEBI:4911

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:4911

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:4911

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:4911

object_name: Mycosis fungoides/Sezary syndrome stage II


subject: CHEBI:4911

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:4911

object_name: Mycosis fungoides/Sezary syndrome stage I


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: Mantle cell lymphoma stage I


subject: CHEBI:5864

object_name: Mantle cell lymphoma stage III


subject: CHEBI:5864

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:5864

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:5864

object_name: Cutaneous T-cell lymphoma stage I


subject: CHEBI:5864

object_name: Cutaneous T-cell lymphoma stage II


subject: CHEBI:5864

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:5864

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:5864

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:5864

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:5864

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:5864

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: CHEBI:5864

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: CHEBI:5864

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:5864

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:5864

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:5864

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:5864

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:5864

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:5864

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:5864

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:5864

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:5864

object_name: MALT lymphoma


subject: CHEBI:5864

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:5864

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:5864

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:5864

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:5864

object_name: splenic marginal zone lymphoma


subject: CHEBI:5864

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:5864

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:5864

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:5864

object_name: Mycosis fungoides/Sezary syndrome stage II


subject: CHEBI:5864

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:5864

object_name: Mycosis fungoides/Sezary syndrome stage I


subject: CHEBI:5864

object_name: Waldenstrom macroglobulinemia


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Mantle cell lymphoma stage I


subject: CHEBI:45716

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: CHEBI:45716

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: CHEBI:45716


subject: CHEBI:45716


subject: UMLS:C5669600

subject_name: Ivonescimab

object_name: female reproductive organ cancer


subject: UMLS:C5669600

object_name: cervical cancer


subject: UMLS:C5669600

object_name: uterine cervix neoplasm


subject: UMLS:C5669600

object_name: cervical polyp


subject: UMLS:C5669600

object_name: Cervical neoplasm


subject: UMLS:C5669600

object_name: endometrium neoplasm


subject: UMLS:C5669600

object_name: ovarian cancer


subject: UMLS:C5669600

object_name: ovarian neoplasm


subject: UNII:21K6M2I7AG

subject_name: interferon gamma-1b

object_name: acute myeloid leukemia by FAB classification


subject: UNII:21K6M2I7AG

object_name: acute myeloid leukemia


subject: UNII:21K6M2I7AG

object_name: Myelodysplasia


subject: UMLS:C0021741

subject_name: Actimmune


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: post-operative delirium


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:60799

subject_name: Esketamine


subject: CHEBI:4856

subject_name: Esmolol

object_name: Postoperative delirium


subject: CHEBI:4856

object_name: Emergence Delirium


subject: CHEBI:4856


subject: UMLS:C5238055

subject_name: Tengonermin

object_name: Pleural mesothelioma malignant advanced


subject: UMLS:C1143119

subject_name: Zafiride


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: B-cell chronic lymphocytic leukemia, in relapse


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: CHEBI:133021

subject_name: Venetoclax


subject: PUBCHEM.COMPOUND:169422749

object_name: Malignant neoplasm of female breast


subject: UMLS:C5554958

subject_name: Recombinant HSA/G-CSF Fusion Protein MW05


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: Thromboembolism


subject: PUBCHEM.COMPOUND:25476

subject_name: Angiotensina II

object_name: Intraoperative hypotension


subject: PUBCHEM.COMPOUND:25476

object_name: Shock


subject: PUBCHEM.COMPOUND:25476

object_name: Post procedural hypotension


subject: PUBCHEM.COMPOUND:25476

object_name: hypotension and shock


subject: PUBCHEM.COMPOUND:25476

object_name: Disorder of transplanted kidney


subject: PUBCHEM.COMPOUND:25476

object_name: surgical shock


subject: CHEBI:2719

subject_name: Angiotensin II


subject: CHEBI:2719


subject: CHEBI:2719


subject: CHEBI:2719


subject: CHEBI:2719


subject: CHEBI:2719


subject: PR:000036009

subject_name: angiotensin II


subject: PR:000036009


subject: PR:000036009


subject: PR:000036009


subject: PR:000036009


subject: PR:000036009


subject: UMLS:C5400662

subject_name: Therapeutic Angiotensin II


subject: UMLS:C5400662


subject: UMLS:C5400662


subject: UMLS:C5400662


subject: UMLS:C5400662


subject: UMLS:C5400662


subject: CHEBI:57694

object_name: coronary artery disorder


subject: CHEBI:57694

object_name: coronary atherosclerosis


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: UMLS:C0666155

subject_name: ABT 089

object_name: nicotine dependence


subject: UMLS:C0666155

object_name: Nicotine Addiction


subject: DRUGBANK:DB15656

subject_name: ChAdOx1 nCoV-19

object_name: Coronavinae infectious disease


subject: UMLS:C1831888

object_name: lung cancer


subject: UMLS:C1831888

object_name: lung neoplasm


subject: UMLS:C1831888

object_name: lung carcinoma


subject: CHEBI:149837

subject_name: Alisporivir

object_name: liver failure


subject: UMLS:C1567950

subject_name: alisporivir


subject: PUBCHEM.COMPOUND:67454400

subject_name: reldesemtiv

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: PUBCHEM.COMPOUND:67454400

object_name: amyotrophic lateral sclerosis


subject: UNII:4S0HBYW6QE

subject_name: Reldesemtiv


subject: UNII:4S0HBYW6QE


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist

object_name: endometriosis


subject: UMLS:C5666954

subject_name: Survivin-targeted Vaccine OVM-200

object_name: ovarian cancer


subject: UMLS:C5666954

object_name: ovarian neoplasm


subject: UMLS:C5666954

object_name: ovarian carcinoma


subject: UMLS:C5666954

object_name: prostate carcinoma


subject: UMLS:C5666954

object_name: prostate cancer


subject: UMLS:C5666954

object_name: non-small cell lung carcinoma


subject: CHEBI:136036

subject_name: Cridanimod

object_name: influenza


subject: CHEBI:136036

object_name: Acute respiratory infections


subject: PUBCHEM.COMPOUND:53744

subject_name: 9-Oxo-10-acridineacetic acid


subject: PUBCHEM.COMPOUND:53744


subject: UMLS:C0908045

subject_name: cycloferon


subject: UMLS:C0908045


subject: CHEBI:31587

subject_name: Exatecan mesilate hydrate


subject: CHEBI:31587


subject: CHEBI:31587


subject: CHEBI:135709

subject_name: Exatecan


subject: CHEBI:135709


subject: CHEBI:135709


subject: UMLS:C0935945

subject_name: exatecan mesylate


subject: UMLS:C0935945


subject: UMLS:C0935945


subject: GTOPDB:7730

subject_name: bococizumab

object_name: Familial hypercholesterolemia - heterozygous


subject: CHEMBL.COMPOUND:CHEMBL3137349

subject_name: BOCOCIZUMAB


subject: UMLS:C4043705


subject: UMLS:C5227743


subject: UMLS:C4550206


subject: UMLS:C1170120

subject_name: Caphosol

object_name: Halitosis


subject: UMLS:C1832026

object_name: colorectal cancer


subject: UMLS:C1832026

object_name: colorectal carcinoma


subject: UMLS:C1832026

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1832026

object_name: colorectal neoplasm


subject: CHEBI:87681

subject_name: Ranolazine

object_name: Ischaemic mitral regurgitation


subject: UMLS:C2983767

object_name: metastatic colorectal cancer


subject: UMLS:C3641686

subject_name: Technetium Tc 99m-3PRGD2

object_name: rheumatoid arthritis


subject: UMLS:C5557461

object_name: asthma


subject: CHEBI:3077

subject_name: Betamethasone

object_name: temporal arteritis


subject: CHEBI:3077

object_name: polymyalgia rheumatica


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: portal hypertension


subject: UNII:28X28X9OKV

object_name: Portal Hypertension, CTCAE


subject: UNII:28X28X9OKV

object_name: Cirrhosis


subject: UNII:28X28X9OKV

object_name: liver cirrhosis


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:28876

subject_name: Melphalan

object_name: diffuse intrinsic pontine glioma


subject: UNII:6K6L7E3F1L

subject_name: Gefapixant

object_name: Chronic refractory cough


subject: UNII:D733ET3F9O

subject_name: crisantaspase

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:D733ET3F9O

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:D733ET3F9O

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C0591457

subject_name: Erwinase


subject: UMLS:C0591457


subject: UMLS:C0591457


subject: CHEBI:40799

subject_name: Boldione

object_name: Oligometastatic Prostate Carcinoma


subject: PR:000011408

subject_name: nuclear receptor subfamily 4 immunity group A member 1

object_name: inherited lipid metabolism disorder


subject: PR:000011408

object_name: Chronic metabolic disorder


subject: PR:000011408

object_name: sarcopenia


subject: CHEBI:133021

subject_name: Venetoclax

object_name: refractory hairy cell leukemia


subject: CHEBI:133021

object_name: Recurrent Hairy Cell Leukemia Variant


subject: CHEBI:90943

subject_name: Osimertinib

object_name: Mesothelioma


subject: CHEBI:90943

object_name: mesothelial neoplasm


subject: CHEBI:90943

object_name: malignant mesothelioma


subject: PUBCHEM.COMPOUND:155214091


subject: PUBCHEM.COMPOUND:155214091


subject: PUBCHEM.COMPOUND:155214091


subject: PUBCHEM.COMPOUND:155214091

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:155214091

object_name: non-small cell lung carcinoma


subject: UMLS:C5555858

subject_name: TEAD Inhibitor VT3989


subject: UMLS:C5555858


subject: UMLS:C5555858


subject: UMLS:C5555858


subject: UMLS:C5555858


subject: UNII:UYB6UOF69L

subject_name: Maralixibat

object_name: progressive familial intrahepatic cholestasis


subject: UNII:28X28X9OKV

object_name: esophageal adenocarcinoma


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

object_name: metastatic colorectal cancer


subject: UNII:QEN1X95CIX

object_name: triple-negative breast carcinoma


subject: UNII:QEN1X95CIX

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:18258

subject_name: Liothyronine

object_name: hypothyroidism


subject: CHEBI:18258

object_name: Hypothyroidism, CTCAE


subject: UMLS:C4526674

subject_name: Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6


subject: UMLS:C4526674


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: interstitial cystitis


subject: MESH:C000721064

object_name: chronic hepatitis B virus infection


subject: MESH:C000721064

object_name: hepatitis B


subject: CHEBI:231601

subject_name: trastuzumab

object_name: cardiotoxicity


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:28976

subject_name: carbonic acid

object_name: cystic fibrosis


subject: UMLS:C2722820

subject_name: Bicarbonate preparation


subject: MESH:D001639

subject_name: Bicarbonates


subject: CHEBI:17544

subject_name: Bicarbonate Ion


subject: CHEBI:167672

subject_name: Tovorafenib

object_name: RAF Family Gene Mutation


subject: CHEBI:167672

object_name: RAS Family Gene Mutation


subject: CHEBI:167672

object_name: ERK Family Gene Mutation


subject: CHEBI:167672


subject: CHEBI:167672

object_name: MEK Family Gene Mutation


subject: CHEBI:167672

object_name: childhood pilocytic astrocytoma


subject: CHEBI:167672

object_name: Adult Pilocytic Astrocytoma


subject: CHEBI:167672

object_name: Spongioblastoma


subject: CHEBI:167672

object_name: colorectal cancer


subject: CHEBI:167672

object_name: colorectal carcinoma


subject: CHEBI:167672

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:167672

object_name: pancreatic neoplasm


subject: CHEBI:167672

object_name: exocrine pancreatic carcinoma


subject: CHEBI:167672

object_name: malignant pancreatic neoplasm


subject: CHEBI:94793

subject_name: Pimasertib

object_name: melanoma


subject: CHEBI:94793

object_name: Childhood Solid Neoplasm


subject: CHEBI:94793

object_name: Adult Solid Neoplasm


subject: CHEBI:94793


subject: CHEBI:94793


subject: CHEBI:94793


subject: CHEBI:94793

object_name: non-small cell lung carcinoma


subject: CHEBI:94793


subject: CHEBI:94793


subject: CHEBI:94793


subject: CHEBI:94793


subject: CHEBI:94793


subject: CHEBI:94793


subject: CHEBI:94793


subject: CHEBI:94793


subject: CHEBI:94793


subject: CHEBI:94793


subject: UNII:TUK9QB44B0

object_name: acquired idiopathic inflammatory myopathy


subject: UNII:TUK9QB44B0

object_name: idiopathic inflammatory myopathy


subject: UNII:TUK9QB44B0

object_name: juvenile dermatomyositis


subject: UNII:TUK9QB44B0

object_name: myositis


subject: UNII:TUK9QB44B0

object_name: Myositis, CTCAE 5.0


subject: UMLS:C5392518


subject: UMLS:C5392518


subject: UMLS:C5392518


subject: UMLS:C5392518


subject: UMLS:C5392518


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C4289970

object_name: clear cell renal carcinoma


subject: UMLS:C4289970

object_name: renal cell adenocarcinoma


subject: UMLS:C4289970

object_name: renal cell carcinoma


subject: UNII:LOG73M21H5

subject_name: SUZETRIGINE

object_name: Acute Pain


subject: CHEBI:233446

subject_name: suzetrigine


subject: PUBCHEM.COMPOUND:14883207

subject_name: IMPLANON

object_name: Uses contraception (finding)


subject: UMLS:C0673606

subject_name: Implanon


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Obesity, Visceral


subject: PUBCHEM.COMPOUND:155543961

object_name: inherited lipid metabolism disorder


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: ankylosing spondylitis


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:4445

subject_name: Desflurane

object_name: Intensive care unit syndrome


subject: CHEBI:6015

subject_name: Isoflurane


subject: CHEBI:9130

subject_name: Sevoflurane


subject: UNII:ZLW14X2D30

object_name: inborn error of immunity


subject: UNII:ZLW14X2D30

object_name: pelvic inflammatory disease


subject: UMLS:C0108779

subject_name: CD3 Antigens


subject: UMLS:C0108779


subject: CHEBI:18132

subject_name: phosphocholine

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:18132

object_name: Lymphoma, Large-Cell, Follicular


subject: UniProtKB:Q62857

subject_name: DDIT3_RAT DNA damage-inducible transcript 3 protein (sprot)


subject: UniProtKB:Q62857


subject: PR:000006347

subject_name: DNA damage-inducible transcript 3 protein


subject: PR:000006347


subject: CHEBI:39112

subject_name: Bosutinib

object_name: CD22 Positive


subject: CHEBI:39112

object_name: Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: CHEBI:39112

object_name: Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: CHEBI:39112

object_name: Ph-positive acute lymphoblastic leukemia


subject: CHEBI:39112

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:39112

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:39112

object_name: Blasts More than 5 Percent of Bone Marrow Nucleated Cells


subject: UNII:P93RUU11P7

subject_name: INOTUZUMAB


subject: UNII:P93RUU11P7


subject: UNII:P93RUU11P7


subject: UNII:P93RUU11P7


subject: UNII:P93RUU11P7

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:P93RUU11P7

object_name: Blast Phase


subject: UNII:P93RUU11P7


subject: UNII:P93RUU11P7


subject: UNII:P93RUU11P7


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C4552025

subject_name: Thymidine Kinase (-) Vaccinia-GM-CSF JX-594 Vaccine

object_name: ovarian cancer


subject: UMLS:C4552025

object_name: ovarian neoplasm


subject: UMLS:C4552025

object_name: ovarian carcinoma


subject: PR:000001543

subject_name: programmed cell death 1 ligand 1

object_name: metastatic melanoma


subject: UMLS:C2986400

subject_name: Indoleamine 2,3-dioxygenase Peptide Vaccine


subject: CHEBI:95165

object_name: precancerous condition


subject: CHEBI:95165

object_name: adult lymphoma


subject: CHEBI:95165

object_name: lymphoma


subject: CHEBI:95165

object_name: pediatric lymphoma


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage IA Esophageal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: stage IA esophageal cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage IB Esophageal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: stage IB esophageal cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIA Esophagus Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIB Esophageal Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: stage IIIC esophageal cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC Esophageal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: stage IIIB esophageal cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIB Esophageal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIA Esophageal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: stage IIIA esophageal cancer


subject: UNII:2S9ZZM9Q9V

object_name: esophageal squamous cell carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: esophageal adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Gastric Mixed Adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: diffuse gastric adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: gastric intestinal type adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIA Gastric Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIB Gastric Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC Gastric Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIB Gastric Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIA Gastric Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IA Gastric Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IB Gastric Carcinoma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Stage IA Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: stage IA esophageal cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IB Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: stage IB esophageal cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIA Esophagus Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIB Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: stage IIIC esophageal cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIC Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: stage IIIB esophageal cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIB Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIA Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: stage IIIA esophageal cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIA Gastric Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIB Gastric Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640

object_name: esophageal squamous cell carcinoma


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640

object_name: Stage IA Gastric Carcinoma


subject: CHEBI:15640

object_name: Stage IB Gastric Carcinoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Stage IA Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: stage IA esophageal cancer


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IB Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: stage IB esophageal cancer


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIA Esophagus Carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIB Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: stage IIIC esophageal cancer


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIC Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: stage IIIB esophageal cancer


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIB Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIA Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: stage IIIA esophageal cancer


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIA Gastric Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIB Gastric Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:15365

subject_name: Aspirin

object_name: female infertility


subject: CHEBI:231678

subject_name: Evofosfamide

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:231678

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:231678

object_name: sarcoma


subject: CHEBI:231678

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:231678

object_name: soft tissue sarcoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Radiculopathy, Cervical


subject: PUBCHEM.COMPOUND:89455219

subject_name: tirabrutinib

object_name: rheumatoid arthritis


subject: CHEBI:9123

subject_name: Sertraline

object_name: acute coronary syndrome


subject: CHEBI:36791

subject_name: Escitalopram


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:6605

subject_name: lysergide

object_name: anxiety disorder


subject: CHEBI:6605

object_name: post-traumatic stress disorder


subject: PR:000006595

subject_name: deoxyribonuclease gamma


subject: PR:000006595


subject: UMLS:C1528962

subject_name: Metalyse

object_name: myocardial infarction


subject: UMLS:C1528962

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C1528962

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C0790233

subject_name: Distilled water

object_name: superficial urinary bladder carcinoma


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic


subject: UMLS:C0445115

subject_name: Normal saline


subject: CHEBI:36796

subject_name: duloxetine

object_name: Drug action (disorder)


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: UNII:FYS6T7F842

object_name: reactive angioendotheliomatosis


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Rash and Dermatitis Associated with Radiation Excluding Chemoradiation, CTCAE


subject: CHEBI:45863

object_name: radiation exposure measurement


subject: CHEBI:45863

object_name: metastatic malignant neoplasm in the lymph nodes


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: UMLS:C1831824

object_name: mantle cell lymphoma


subject: UMLS:C1831824

object_name: Childhood Diffuse Large Cell Lymphoma


subject: UMLS:C1831824

object_name: diffuse large B-cell lymphoma


subject: UMLS:C1831824

object_name: Adult Diffuse Large Cell Lymphoma


subject: UMLS:C1831824

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C1831824

object_name: follicular lymphoma


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: impotence


subject: CHEBI:16480

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:16480

object_name: Erectile dysfunction


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:44423

object_name: acute myeloid leukemia


subject: CHEBI:17026

subject_name: Progesterone

object_name: Diffuse traumatic cerebral edema


subject: GTOPDB:11827

subject_name: telitacicept

object_name: antiphospholipid syndrome


subject: CHEMBL.COMPOUND:CHEMBL5095293

subject_name: TELITACICEPT


subject: UMLS:C5238006


subject: PR:000017019

subject_name: UBX domain-containing protein 11


subject: UMLS:C1882413

subject_name: Poly(ADP-ribose) Polymerase Inhibitors

object_name: lung cancer


subject: UMLS:C1882413

object_name: lung neoplasm


subject: UMLS:C1882413

object_name: lung carcinoma


subject: UMLS:C4019076

subject_name: Poly(ADP-Ribose) Polymerase Inhibitor [EPC]


subject: UMLS:C4019076


subject: UMLS:C4019076


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)


subject: UMLS:C4086713


subject: UMLS:C4086713


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Brain Stem Glioblastoma


subject: CHEBI:4026

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:4026

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:4026

object_name: glioma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:230682

subject_name: Indoximod


subject: CHEBI:230682


subject: CHEBI:230682


subject: CHEBI:230682

object_name: Adult Gliosarcoma


subject: CHEBI:230682

object_name: gliosarcoma


subject: CHEBI:230682

object_name: Childhood Gliosarcoma


subject: CHEBI:230682


subject: CHEBI:230682

object_name: malignant glioma


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib

object_name: Follicular lymphoma recurrent


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: systolic heart failure


subject: CHEBI:3441

subject_name: Carvedilol

object_name: atrial fibrillation


subject: CHEBI:3441

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:3441

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:74854

subject_name: Thr-Asp

object_name: benign prostatic hyperplasia


subject: UMLS:C3526553

subject_name: diphtheria, tetanus toxoids and acellular pertussis vaccine


subject: UMLS:C0305060

subject_name: Tetanus and diphtheria toxoid adsorbed for adult use


subject: CHEBI:33380

subject_name: thulium atom


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: UMLS:C3166394

subject_name: Tm antigen


subject: PR:000002105

subject_name: thrombomodulin


subject: CHEBI:36796

subject_name: duloxetine

object_name: male infertility


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:51254

object_name: obesity


subject: CHEBI:51254

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: CHEBI:48947


subject: CHEBI:48947


subject: UNII:MT6QI8324A

subject_name: Magnesium lactate

object_name: pregnancy related


subject: CHEBI:3441

object_name: Becker muscular dystrophy


subject: CHEBI:3441

object_name: Duchenne muscular dystrophy


subject: CHEBI:8774

subject_name: Ramipril


subject: CHEBI:8774


subject: UMLS:C4053647

object_name: Alzheimer disease type 1


subject: UNII:I8C3R768IZ

subject_name: Vamotinib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: adult acute myeloid leukemia


subject: UNII:I031V2H011

object_name: childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: Locally advanced breast cancer


subject: PUBCHEM.COMPOUND:135565596

object_name: Carcinoma breast stage IV


subject: CHEBI:173077


subject: CHEBI:173077


subject: UMLS:C2826229


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: diabetic neuropathy


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Refractory Liver Carcinoma


subject: CHEBI:4026

object_name: Recurrent Hepatocellular Carcinoma


subject: CHEBI:4026

object_name: Stage IV Hepatocellular Carcinoma AJCC v8


subject: CHEBI:4026

object_name: Stage IVB Hepatocellular Carcinoma AJCC v8


subject: CHEBI:4026

object_name: Stage IVA Hepatocellular Carcinoma AJCC v8


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: UMLS:C0758290

subject_name: IRX 2


subject: UMLS:C0758290


subject: UMLS:C0758290


subject: UMLS:C0758290


subject: UMLS:C0758290


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C4724858

object_name: RET gene mutation


subject: UMLS:C4724858

object_name: BRAF gene mutation


subject: UMLS:C4724858

object_name: ovarian cancer


subject: UMLS:C4724858

object_name: ovarian neoplasm


subject: UMLS:C4724858

object_name: ovarian carcinoma


subject: UMLS:C4724858

object_name: non-small cell lung carcinoma


subject: MESH:C571726

subject_name: shinbaro

object_name: Heberden node


subject: MESH:C571726

object_name: osteoarthritis, hand


subject: UMLS:C3491817


subject: UMLS:C3491817


subject: CHEBI:18361

object_name: Helicobacter pylori infectious disease


subject: CHEBI:53266

subject_name: poly(propylene imine) macromolecule


subject: CHEBI:35782

subject_name: diphosphate ion


subject: CHEBI:60614

subject_name: poly(propylene imine) polymer


subject: CHEBI:29888

subject_name: Pyrophosphate


subject: UMLS:C0358591

subject_name: Proton Pump Inhibitors


subject: CHEBI:49200

subject_name: EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor


subject: UMLS:C3536754

subject_name: Proton Pump Inhibitor [EPC]


subject: CHEBI:16646

subject_name: carbohydrate

object_name: Fasting


subject: UNII:2AW48LAZ4I

subject_name: IMETELSTAT SODIUM

object_name: plasma cell myeloma


subject: UNII:F60NE4XB53

subject_name: imetelstat


subject: UMLS:C4282299


subject: UMLS:C3489751

object_name: acute coronary syndrome


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: squamous cell carcinoma of rectum


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: CHEBI:23080

subject_name: cerotoyl group


subject: PR:000015192

subject_name: sodium- and chloride-dependent creatine transporter 1


subject: UMLS:C4733684

object_name: oral cavity squamous cell carcinoma


subject: UMLS:C4733683

subject_name: Cisplatin Transmucosal Patch


subject: UNII:V5Y646AW8S

object_name: influenza


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:6538

subject_name: Loratadine


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: UMLS:C3661295

object_name: type 1 diabetes mellitus 1


subject: UMLS:C3661295

object_name: type 1 diabetes mellitus


subject: UMLS:C0352868

subject_name: Metronidazole gel

object_name: gingivitis


subject: DRUGBANK:DB10655

subject_name: Macadamia nut

object_name: Heart Disease Risk Factors


subject: DRUGBANK:DB10655

object_name: heart disorder


subject: DRUGBANK:DB10655

object_name: Inflammation


subject: UMLS:C0967936

subject_name: IH636 grape seed proanthocyanidin extract

object_name: Atherosclerosis of arteries of the extremities, unspecified


subject: CHEBI:74705

subject_name: Met-Leu

object_name: maple syrup urine disease type 1A


subject: CHEBI:74705

object_name: maple syrup urine disease


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEBI:52763


subject: CHEBI:52763


subject: CHEBI:597326

subject_name: pyridoxal 5'-phosphate(2-)

object_name: pervasive developmental disorder


subject: CHEBI:597326

object_name: autism


subject: CHEBI:18405

subject_name: Pyridoxal phosphate


subject: CHEBI:18405


subject: CHEBI:17310

subject_name: Pyridoxal


subject: CHEBI:17310


subject: CHEBI:75551


subject: CHEBI:75551


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody

object_name: Advanced cancer


subject: UMLS:C4289970

object_name: pancreatic ductal adenocarcinoma


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:64816

object_name: HER2 positive breast carcinoma


subject: UMLS:C5418023

subject_name: LSD1 Inhibitor SYHA1807

object_name: Small cell lung cancer extensive stage


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Recurrent mouth ulcers


subject: CHEBI:25681

object_name: aphthous stomatitis


subject: UMLS:C5139955

object_name: Atopic rhinitis


subject: UMLS:C5139955

object_name: Allergic Rhinitis, CTCAE


subject: UMLS:C4726648

subject_name: Quilizumab


subject: UMLS:C4726648


subject: MESH:C461320

subject_name: shosaiko-to

object_name: hepatitis C


subject: PUBCHEM.COMPOUND:65404

subject_name: fanasil, pyrimethamine drug combination

object_name: sickle cell disease


subject: UMLS:C0700599

subject_name: pyrimethamine / sulfadoxine


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: pneumocystosis


subject: CHEBI:6888

object_name: HIV infection


subject: CHEBI:36791

subject_name: Escitalopram

object_name: major depressive episode


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:231605

subject_name: Telaglenastat

object_name: Childhood Solid Neoplasm


subject: CHEBI:231605

object_name: Adult Solid Neoplasm


subject: CHEBI:231605

object_name: Solid Neoplasm


subject: CHEBI:231605

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:231605

object_name: clear cell renal carcinoma


subject: CHEBI:231605

object_name: renal cell adenocarcinoma


subject: CHEBI:231605

object_name: refractory cytopenia of childhood


subject: CHEBI:231605

object_name: renal cell carcinoma


subject: CHEBI:231605

object_name: colorectal cancer


subject: CHEBI:231605

object_name: colorectal carcinoma


subject: CHEBI:231605

object_name: triple-negative breast carcinoma


subject: CHEBI:231605

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: GTOPDB:8313

subject_name: talazoparib


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: CHEBI:5130

subject_name: Flurbiprofen

object_name: Upper Respiratory Infections


subject: CHEBI:5130

object_name: respiratory tract infectious disorder


subject: CHEBI:5130

object_name: Recurrent upper respiratory tract infections


subject: CHEBI:5130

object_name: Cough


subject: CHEBI:5130

object_name: Cough, CTCAE


subject: PUBCHEM.COMPOUND:71300864

object_name: impotence


subject: PUBCHEM.COMPOUND:71300864

object_name: Erectile Dysfunction, CTCAE


subject: PUBCHEM.COMPOUND:71300864

object_name: Erectile dysfunction


subject: PUBCHEM.COMPOUND:71300864

object_name: systolic heart failure


subject: UMLS:C2933615

subject_name: LCZ 696


subject: UMLS:C2933615


subject: UMLS:C2933615


subject: UMLS:C2933615


subject: UMLS:C5203352

subject_name: Carboplatin Liquid Injection

object_name: non-small cell lung carcinoma


subject: UMLS:C0499106

subject_name: Injection, carboplatin, 50 mg


subject: UMLS:C5400115

subject_name: Cisplatin Liquid Injection


subject: CHEMBL.COMPOUND:CHEMBL4650387

object_name: metastatic melanoma


subject: PUBCHEM.COMPOUND:86217377

subject_name: Oxybutynin AL

object_name: Effects of heat


subject: CHEBI:144551

subject_name: Oxybutynin


subject: UMLS:C1446848

subject_name: Silk antigen

object_name: leukemia


subject: UMLS:C1446848

object_name: childhood leukemia


subject: UMLS:C1446848

object_name: Non-Hodgkin's lymphoma of intestine


subject: DRUGBANK:DB10609

subject_name: Bombyx mori fiber


subject: DRUGBANK:DB10609


subject: DRUGBANK:DB10609


subject: UMLS:C0074529

subject_name: Silk


subject: UMLS:C0074529


subject: UMLS:C0074529


subject: GTOPDB:11592

subject_name: evorpacept

object_name: oropharyngeal carcinoma


subject: GTOPDB:11592

object_name: oropharynx cancer


subject: CHEMBL.COMPOUND:CHEMBL4297880

subject_name: EVORPACEPT


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: UMLS:C0219461

subject_name: regramostim

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:233453

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:35854

subject_name: Valaciclovir


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:63635

subject_name: Valganciclovir


subject: CHEBI:63635


subject: CHEBI:63635


subject: CHEBI:4708

subject_name: Doxazosin

object_name: cocaine dependence


subject: CHEBI:230791

subject_name: tributyrylglycerol

object_name: Parkinson disease


subject: CHEBI:35020

subject_name: Tributyrin


subject: MESH:C556497

object_name: adrenogenital syndrome


subject: MESH:C556497

object_name: congenital adrenal hyperplasia


subject: CHEBI:6931

subject_name: Midazolam

object_name: chronic disease


subject: CHEBI:6931

object_name: Chronic Disease


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:75722


subject: CHEBI:193860

subject_name: Chymopapain

object_name: carcinoma of esophagus


subject: CHEBI:193860

object_name: esophageal cancer


subject: CHEBI:193860

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:193860

object_name: neoplasm of esophagus


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Knee Injuries


subject: CHEBI:66964

object_name: Injury of ligament of knee


subject: CHEBI:66964

object_name: Injury of articular cartilage of left knee joint


subject: CHEBI:66964

object_name: Injury of articular cartilage of right knee joint


subject: CHEBI:66964

object_name: Synovitis of knee


subject: CHEBI:66964

object_name: Loose body in knee


subject: CHEBI:66964

object_name: Finding of tear meniscus (eye)


subject: CHEBI:66964

object_name: Torn meniscus


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: opiate dependence


subject: UMLS:C2348756

subject_name: Testosterone Gel

object_name: Uses contraception (finding)


subject: UniProtKB:P04276

subject_name: VTDB_RAT Vitamin D-binding protein (sprot)

object_name: hypertension


subject: UniProtKB:P04276

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:9830161

subject_name: Morphine Oxycodone

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:9830161

object_name: opioid use


subject: PUBCHEM.COMPOUND:23728926

subject_name: RESOMELAGON

object_name: dengue disease


subject: UMLS:C5783738

subject_name: Resomelagon


subject: UMLS:C5854455

subject_name: Therapeutic Cancer Vaccine ATP150

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5854456

subject_name: Therapeutic Cancer Vaccine ATP152


subject: UNII:5V1UI86573

subject_name: EZABENLIMAB


subject: UMLS:C4329334

subject_name: Ezabenlimab


subject: UMLS:C5854454

subject_name: VSV-GP-based Cancer Vaccine VSV-GP154


subject: CHEBI:4696

subject_name: donepezil hydrochloride

object_name: amnesia


subject: CHEBI:145499

subject_name: Donepezil


subject: UMLS:C4743433

subject_name: onabotulinum toxin A

object_name: benign prostatic hyperplasia


subject: UNII:F0LZ415Z3B

subject_name: Tixagevimab

object_name: Coronavinae infectious disease


subject: CHEBI:32660

subject_name: asparaginase

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:32660

object_name: childhood myelodysplastic syndrome


subject: CHEBI:32660

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:32660

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:32660

object_name: untreated childhood acute myeloid leukemia and other myeloid malignancies


subject: CHEBI:32660

object_name: childhood acute myeloid leukemia with maturation


subject: CHEBI:32660

object_name: Childhood Acute Myeloid Leukemia without Maturation


subject: CHEBI:32660

object_name: Childhood Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:32660

object_name: Childhood Acute Myelomonocytic Leukemia


subject: CHEBI:32660

object_name: Childhood Acute Monoblastic Leukemia


subject: CHEBI:32660

object_name: childhood acute monocytic leukemia


subject: CHEBI:32660

object_name: Childhood Acute Erythroid Leukemia


subject: CHEBI:32660

object_name: childhood acute megakaryoblastic leukemia


subject: CHEBI:32660

object_name: Childhood Acute Basophilic Leukemia


subject: CHEBI:32660

object_name: Childhood Acute Eosinophilic Leukemia


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: UNII:FTK8U1GZNX

subject_name: THIOGUANINE


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: CHEBI:9555

subject_name: Tioguanine


subject: CHEBI:9555


subject: CHEBI:9555


subject: CHEBI:9555


subject: CHEBI:9555


subject: CHEBI:9555


subject: CHEBI:9555


subject: CHEBI:9555


subject: CHEBI:9555


subject: CHEBI:9555


subject: CHEBI:9555


subject: CHEBI:9555


subject: CHEBI:9555


subject: CHEBI:9555


subject: CHEBI:9555


subject: PUBCHEM.COMPOUND:5148108

subject_name: Resiniferatoxin

object_name: osteoarthritis, knee


subject: PUBCHEM.COMPOUND:5148108

object_name: knee pain chronic


subject: CHEBI:6801

subject_name: Metformin

object_name: periodontitis, chronic, adult


subject: CHEBI:6801

object_name: chronic periodontitis


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:38545


subject: CHEBI:33349

subject_name: dubnium atom

object_name: high-risk pregnancy


subject: CHEBI:33357

subject_name: hassium atom


subject: CHEBI:133630

subject_name: His-Ala


subject: UniProtKB:P03456

subject_name: HEMA_I68A3 Hemagglutinin (sprot)


subject: UniProtKB:P03446

subject_name: HEMA_I76A2 Hemagglutinin (sprot)


subject: UniProtKB:A3DRP0

subject_name: HEMA_I96A2 Hemagglutinin (sprot)


subject: UniProtKB:A4K143

subject_name: HEMA_I54A2 Hemagglutinin (sprot)


subject: UniProtKB:B4URD6

subject_name: HEMA_I06A0 Hemagglutinin (sprot)


subject: UniProtKB:Q0A448

subject_name: hemagglutinin (Influenza A virus (strain A/Duck/Germany/1949 H10N7))


subject: UMLS:C4285347

subject_name: Ha Antibody


subject: UniProtKB:Q9WCD8

subject_name: HEMA_I61A1 Hemagglutinin (sprot)


subject: UniProtKB:P03453

subject_name: HEMA_I77AB Hemagglutinin (sprot)


subject: UniProtKB:A4U7A6

subject_name: HEMA_I51A0 Hemagglutinin (sprot)


subject: UniProtKB:P13103

subject_name: HEMA_I77AF Hemagglutinin (sprot)


subject: UniProtKB:P26136

subject_name: HEMA_I82A1 Hemagglutinin (sprot)


subject: UniProtKB:P07976

subject_name: HEMA_I83A5 Hemagglutinin (sprot)


subject: UniProtKB:A4GBX7

subject_name: HEMA_I77AA Hemagglutinin (sprot)


subject: UniProtKB:P19698

subject_name: HEMA_I79A7 Hemagglutinin (sprot)


subject: UniProtKB:Q6LEJ4

subject_name: HEMA_I80A2 Hemagglutinin (sprot)


subject: UniProtKB:P03457

subject_name: HEMA_I66A1 Hemagglutinin (sprot)


subject: UniProtKB:A4GCL9

subject_name: HEMA_I35A3 Hemagglutinin (sprot)


subject: UniProtKB:Q9WFX3

subject_name: HEMA_I18A0 Hemagglutinin (sprot)


subject: UniProtKB:A4U6V2

subject_name: HEMA_I45A0 Hemagglutinin (sprot)


subject: UniProtKB:Q07FI5

subject_name: HEMA_I96A3 Hemagglutinin (sprot)


subject: UniProtKB:P03454

subject_name: HEMA_I33A0 Hemagglutinin (sprot)


subject: UniProtKB:A4GCK8

subject_name: HEMA_I43A0 Hemagglutinin (sprot)


subject: UniProtKB:P03448

subject_name: HEMA_I72A5 Hemagglutinin (sprot)


subject: UniProtKB:A4GCI6

subject_name: HEMA_I36A0 Hemagglutinin (sprot)


subject: UniProtKB:A4GCJ7

subject_name: HEMA_I80AA Hemagglutinin (sprot)


subject: UniProtKB:P04661

subject_name: HEMA_I56A2 Hemagglutinin (sprot)


subject: UniProtKB:Q0HD60

subject_name: HEMA_I40A0 Hemagglutinin (sprot)


subject: UniProtKB:P26139

subject_name: HEMA_I77A4 Hemagglutinin (sprot)


subject: UniProtKB:A4GCH5

subject_name: HEMA_I83A1 Hemagglutinin (sprot)


subject: UNII:2N4O9L084N

subject_name: Nabilone

object_name: insomnia


subject: UNII:2N4O9L084N

object_name: Insomnia, CTCAE 3.0


subject: UNII:2N4O9L084N

object_name: Insomnia, CTCAE 5.0


subject: DRUGBANK:DB16341

subject_name: Tilsotolimod

object_name: metastatic melanoma


subject: UMLS:C3713821

object_name: opiate dependence


subject: UNII:UVI40IC2GN

subject_name: Carfentanil, C-11


subject: UNII:I7T908772F

subject_name: alum

object_name: skin melanoma


subject: UMLS:C0879386

subject_name: Monoclonal Antibody 4B5 Anti-Idiotype Vaccine


subject: UNII:03J11K103C

subject_name: ALGELDRATE


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: Progression of prostate cancer


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Neuralgia, CTCAE


subject: CHEBI:6456

object_name: Lidocaine adverse reaction


subject: CHEBI:6456

object_name: Local anaesthetic complication


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: Takayasu arteritis


subject: UMLS:C4527301

subject_name: Human papillomavirus virus-like particles conjugated with ir700 dye au-011

object_name: superficial urinary bladder carcinoma


subject: UMLS:C4527301

object_name: Non-Muscle Invasive Bladder Urothelial Carcinoma


subject: UMLS:C4527301

object_name: transitional cell carcinoma


subject: CHEBI:49575

subject_name: Diazepam

object_name: Constipation


subject: CHEBI:49575

object_name: Constipation, CTCAE


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Irreversible pulpitis


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Cognitive impairment


subject: UNII:789Q85GA8P

subject_name: Vorasidenib

object_name: grade II glioma


subject: UNII:789Q85GA8P

object_name: Recurrent Glioma


subject: UMLS:C2703208

subject_name: CDK4 Inhibitor P1446A-05

object_name: Childhood Solid Neoplasm


subject: UMLS:C2703208

object_name: Adult Solid Neoplasm


subject: UMLS:C2703208

object_name: Solid Neoplasm


subject: UMLS:C2703208

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C2703208

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C2703208

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C3641626

subject_name: Targin

object_name: cancer


subject: UMLS:C3641626

object_name: neoplasm


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: coronary stenosis


subject: CHEBI:3215

object_name: coronary artery disorder


subject: CHEBI:3215

object_name: coronary atherosclerosis


subject: CHEBI:3215

object_name: tricuspid valve insufficiency


subject: CHEBI:3215

object_name: mitral valve insufficiency


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Surgical Wound Infection


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: CHEBI:63631

subject_name: Topiramate

object_name: Prader-Willi syndrome


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Chronic neuropathic pain


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Blastocystis hominis Infections


subject: CHEBI:6909

subject_name: Metronidazole


subject: UMLS:C5205491

subject_name: Anti-CD137 Agonistic Monoclonal Antibody ADG106

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:52717

subject_name: Bortezomib

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:52717

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:52717

object_name: Blast Phase


subject: CHEBI:52717

object_name: Childhood Acute Promyelocytic Leukemia


subject: CHEBI:52717

object_name: Childhood Acute Promyelocytic Leukemia with PML-RARA


subject: PUBCHEM.COMPOUND:76022323

subject_name: Idasanutlin

object_name: acquired polycythemia vera


subject: CHEBI:91996

subject_name: Dihydrexidine

object_name: Cognitive impairment


subject: CHEBI:91996

object_name: schizotypal personality disorder


subject: CHEBI:124993


subject: CHEBI:124993


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: lung carcinoma


subject: UMLS:C3827032

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:4672

subject_name: Docetaxel


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: leukopenia


subject: UMLS:C0013227

object_name: neutropenia


subject: UMLS:C0013227

object_name: Febrile Neutropenia


subject: UMLS:C0013227

object_name: Febrile Neutropenia, CTCAE


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604


subject: UMLS:C1870904

subject_name: thromboview

object_name: Deep vein thrombosis of lower limb


subject: UMLS:C1870904

object_name: Deep venous thrombosis


subject: CHEBI:10023

subject_name: Voriconazole

object_name: invasive aspergillosis


subject: UNII:43EP6XV33E

subject_name: Delpazolid

object_name: Mycobacterium abscessus Infection


subject: UNII:43EP6XV33E


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: meningitis


subject: CHEBI:175901

object_name: Meningitis, CTCAE


subject: PUBCHEM.COMPOUND:155269708

subject_name: inlexisertib

object_name: Plexosarcoma


subject: UNII:JM2ZTM8S7S

subject_name: INLEXISERTIB


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: glaucoma


subject: CHEBI:38545

object_name: Glaucoma, CTCAE


subject: CHEBI:135926

subject_name: Udenafil

object_name: Raynaud disease


subject: CHEBI:2668

subject_name: Amlodipine


subject: UMLS:C5226420

object_name: focal epilepsy


subject: CHEBI:53498

subject_name: triacetylcellulose

object_name: autoimmune thrombocytopenia


subject: CHEBI:53498

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:53498

object_name: autoimmune thrombocytopenic purpura


subject: UMLS:C2962221

subject_name: TAC


subject: UMLS:C2962221


subject: UMLS:C2962221


subject: CHEBI:36704

subject_name: Imiquimod

object_name: extramammary Paget disease


subject: CHEBI:46195

subject_name: Acetaminophen


subject: UMLS:C2347401

subject_name: Oral Microencapsulated Diindolylmethane

object_name: healthy, no evidence of disease


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba

object_name: deafness


subject: UNII:19FUJ2C58T

object_name: hearing loss by exam


subject: UNII:19FUJ2C58T

object_name: ototoxicity


subject: UMLS:C4743099

subject_name: GBE 761


subject: UMLS:C4743099


subject: UMLS:C4743099


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: septic abortion


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: UMLS:C0729210

subject_name: Isovue

object_name: thoracic aortic aneurysm


subject: UMLS:C0729210

object_name: Thoracic aortic aneurysm without rupture


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: otitis media


subject: PUBCHEM.COMPOUND:633097

object_name: infectious otitis media


subject: PUBCHEM.COMPOUND:633097

object_name: Otitis Media, CTCAE


subject: PUBCHEM.COMPOUND:633097

object_name: Glue ear


subject: PUBCHEM.COMPOUND:633097

object_name: Adverse effect of radiation therapy


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:94366

subject_name: itraconazole

object_name: Fever


subject: CHEBI:94366

object_name: Fever symptoms (finding)


subject: CHEBI:94366

object_name: Fever, CTCAE


subject: CHEBI:94366

object_name: leukopenia


subject: CHEBI:94366

object_name: neutropenia


subject: CHEBI:94366

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:132922

object_name: sickle cell disease


subject: CHEBI:132922

object_name: hematologic disorder


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: uterine cancer


subject: PUBCHEM.COMPOUND:2767

object_name: tumor of uterus


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors

object_name: Myocardial injury


subject: MESH:D000082082

object_name: myocarditis


subject: MESH:D000082082

object_name: viral myocarditis


subject: MESH:D000082082

object_name: Myocarditis, CTCAE 5.0


subject: MESH:D000082082

object_name: Myocarditis, CTCAE 3.0


subject: MESH:D000082082

object_name: cardiotoxicity


subject: UNII:5G7AKV2MKP

subject_name: Ponesimod

object_name: multiple sclerosis


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: complete trisomy 21


subject: UMLS:C1881373

object_name: Down syndrome


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18332


subject: CHEBI:4875

subject_name: Etanercept

object_name: Pulmonary Complication


subject: CHEBI:4875

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:4875

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:4875

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:4875

object_name: childhood myelodysplastic syndrome


subject: CHEBI:4875

object_name: Recurrent Kidney Wilms Tumor


subject: CHEBI:4875

object_name: Blast Phase


subject: CHEBI:4875

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:4875

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:4875

object_name: Childhood Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:4875

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:4875

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: CHEBI:4875

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:4875

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:4875

object_name: Recurrent Childhood Burkitt Lymphoma


subject: CHEBI:4875

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:4875

object_name: Recurrent Childhood Large Cell Lymphoma


subject: CHEBI:4875

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:4875

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:4875

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:4875

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:4875

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: CHEBI:4875

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:4875

object_name: Disseminated neuroblastoma


subject: CHEBI:4875

object_name: Stage 4S neuroblastoma


subject: CHEBI:4875

object_name: Neuroblastoma recurrent


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B

object_name: Pulmonary Complication


subject: PR:000001959

object_name: De Novo Myelodysplastic Syndrome


subject: PR:000001959

object_name: Secondary Myelodysplastic Syndrome


subject: PR:000001959

object_name: Previously Treated Myelodysplastic Syndrome


subject: PR:000001959

object_name: childhood myelodysplastic syndrome


subject: PR:000001959

object_name: Recurrent Kidney Wilms Tumor


subject: PR:000001959

object_name: Blast Phase


subject: PR:000001959

object_name: Leukemia, Myeloid, Chronic-Phase


subject: PR:000001959

object_name: leukemia, myeloid, accelerated-phase


subject: PR:000001959

object_name: Childhood Acute Lymphoblastic Leukemia in Remission


subject: PR:000001959

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: PR:000001959

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: PR:000001959

object_name: recurrent childhood acute myeloid leukemia


subject: PR:000001959

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: PR:000001959

object_name: Recurrent Childhood Burkitt Lymphoma


subject: PR:000001959

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: PR:000001959

object_name: Recurrent Childhood Large Cell Lymphoma


subject: PR:000001959

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: PR:000001959

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PR:000001959

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PR:000001959

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: PR:000001959

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: PR:000001959

object_name: juvenile myelomonocytic leukemia


subject: PR:000001959

object_name: Disseminated neuroblastoma


subject: PR:000001959

object_name: Stage 4S neuroblastoma


subject: PR:000001959

object_name: Neuroblastoma recurrent


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Pulmonary Complication


subject: CHEBI:6888

object_name: Recurrent Kidney Wilms Tumor


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:18405

subject_name: Pyridoxal phosphate

object_name: pyridoxal phosphate-responsive seizures


subject: CHEBI:17310

subject_name: Pyridoxal


subject: UMLS:C4305937

object_name: pigmentary glaucoma


subject: UMLS:C4305937

object_name: open-angle glaucoma


subject: UMLS:C4305937

object_name: OPTN-related open angle glaucoma


subject: UMLS:C4305937

object_name: ocular hypertension


subject: UMLS:C4305937

object_name: Ocular hypertension


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: carcinoma of esophagus


subject: UMLS:C4764316

subject_name: ProscaVax

object_name: prostate carcinoma


subject: UMLS:C4764316

object_name: prostate cancer


subject: UMLS:C3884660

subject_name: 3K3A-APC protein

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C3884660

object_name: amyotrophic lateral sclerosis


subject: CHEBI:16831

subject_name: Meglutol

object_name: Androgen excess


subject: UMLS:C0178700

subject_name: hydroxymethylglutarate


subject: UNII:41B47ECP9F

subject_name: Dexamethasone sodium sulfate

object_name: Inflammation


subject: UMLS:C0113287

subject_name: dexamethasone sodium sulfate


subject: UMLS:C3714501

subject_name: Insulin Drug Class


subject: UNII:06P3KLK2J8

subject_name: Glofitamab

object_name: Mantle cell lymphoma refractory


subject: UNII:06P3KLK2J8

object_name: Mantle cell lymphoma recurrent


subject: UMLS:C4725069

subject_name: glofitamab


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: CHEBI:94534

subject_name: olanzapine

object_name: borderline personality disorder


subject: UNII:A72V8WPZ9F

subject_name: SURAXAVIR MARBOXIL

object_name: influenza


subject: UNII:QMS40680K6

subject_name: Palifermin

object_name: malignant soft tissue neoplasm


subject: UNII:QMS40680K6

object_name: sarcoma


subject: UMLS:C3530062

object_name: beta thalassemia


subject: DRUGBANK:DB19246

subject_name: Bacillus coagulans

object_name: Nonulcer dyspepsia


subject: DRUGBANK:DB19246

object_name: anxiety


subject: DRUGBANK:DB19246

object_name: anxiety disorder


subject: DRUGBANK:DB19246

object_name: Anxiety symptoms


subject: DRUGBANK:DB19246

object_name: Anxiety, CTCAE 3.0


subject: DRUGBANK:DB19246

object_name: Anxiety, CTCAE 5.0


subject: DRUGBANK:DB19246

object_name: Depressed mood


subject: DRUGBANK:DB19246

object_name: Cancer patients and suicide and depression


subject: DRUGBANK:DB19246

object_name: Depressed - symptom


subject: DRUGBANK:DB19246

object_name: Depression, CTCAE


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: Interstitial lung disease due to systemic disease


subject: UMLS:C0795657

subject_name: Aralast

object_name: type 2 diabetes mellitus


subject: UMLS:C0795657

object_name: Diabetes


subject: UMLS:C0795657

object_name: diabetes mellitus


subject: UMLS:C0002191

subject_name: alpha 1-antitrypsin


subject: UMLS:C0002191


subject: UMLS:C0002191


subject: UMLS:C2343504

subject_name: Aralast NP


subject: UMLS:C2343504


subject: UMLS:C2343504


subject: CHEBI:7025

subject_name: Mupirocin

object_name: folliculitis


subject: CHEBI:7025

object_name: Folliculitis, CTCAE


subject: CHEBI:7025

object_name: cellulitis


subject: CHEBI:7025

object_name: cellulitis on exam (physical finding)


subject: CHEBI:7025

object_name: abscess


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C4043276


subject: UMLS:C3713880

object_name: Community-Acquired Infections


subject: UMLS:C4287739

subject_name: ERK Inhibitor LTT462

object_name: ovarian cancer


subject: UMLS:C4287739

object_name: ovarian neoplasm


subject: DRUGBANK:DB19184

object_name: skin squamous cell carcinoma


subject: DRUGBANK:DB19184

object_name: skin melanoma


subject: DRUGBANK:DB19184

object_name: head and neck squamous cell carcinoma


subject: DRUGBANK:DB19184

object_name: adenoid cystic carcinoma


subject: CHEBI:84739

object_name: ventilator-associated pneumonia


subject: CHEBI:2637

subject_name: Amikacin


subject: CHEBI:134677

subject_name: Crisaborole

object_name: dermatitis


subject: CHEBI:134677

object_name: Eczema, CTCAE


subject: CHEBI:50858

subject_name: corticosteroid

object_name: Hypoxemia


subject: CHEBI:50858

object_name: Blood oxygen concentration below reference range (finding)


subject: CHEBI:50858

object_name: severe acute respiratory syndrome


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: MESH:D000305


subject: MESH:D000305


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: UMLS:C3536709


subject: UMLS:C3536709


subject: UMLS:C1541530

object_name: prostate carcinoma


subject: UMLS:C1541530

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Hepatic and hepatobiliary disorders


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: CHEBI:64212

subject_name: Exisulind

object_name: lung cancer


subject: CHEBI:64212

object_name: lung neoplasm


subject: CHEBI:64212

object_name: lung carcinoma


subject: CHEBI:109549

subject_name: Ramelteon

object_name: cognitive disorder


subject: CHEBI:109549

object_name: Cognitive impairment


subject: CHEBI:109549

object_name: Delayed Emergence from Anesthesia


subject: UNII:I5I8VB78VT

subject_name: Erenumab

object_name: temporomandibular joint disorder


subject: UMLS:C4692289

subject_name: erenumab-aooe


subject: UNII:S82A18Y42P

subject_name: Etripamil

object_name: Paroxysmal supraventricular tachycardia


subject: UMLS:C3666307

subject_name: Rheum palmatum root extract

object_name: Sepsis


subject: UMLS:C3666307

object_name: Sepsis, CTCAE


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: ovarian clear cell cystadenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: ovarian serous cystadenocarcinoma


subject: CHEBI:62880

subject_name: Veliparib

object_name: undifferentiated ovarian carcinoma


subject: CHEBI:62880


subject: CHEBI:62880

object_name: ovarian seromucinous carcinoma


subject: CHEBI:62880


subject: CHEBI:62880

object_name: ovarian endometrioid adenocarcinoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Hodgkin Disease


subject: PUBCHEM.COMPOUND:70789204

object_name: Adult Classical Hodgkin Lymphoma


subject: UNII:19J3781LPM

subject_name: Itacitinib


subject: UNII:19J3781LPM


subject: CHEBI:23359

subject_name: colchicine

object_name: Diabetes


subject: CHEBI:23359

object_name: diabetes mellitus


subject: UMLS:C1330561

subject_name: TheraTears Nutrition

object_name: dry eye syndrome


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: epilepsy


subject: CHEBI:63918

subject_name: Artesunate

object_name: colorectal cancer


subject: CHEBI:63918

object_name: colorectal carcinoma


subject: CHEBI:63918

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:2269

object_name: Chronic obstructive pulmonary disease of horses


subject: PUBCHEM.COMPOUND:2269

object_name: COPD exacerbation


subject: PUBCHEM.COMPOUND:2269

object_name: Asthmatic pulmonary eosinophilia


subject: PUBCHEM.COMPOUND:2269

object_name: immune system disorder


subject: PUBCHEM.COMPOUND:2269

object_name: obstructive lung disease


subject: PUBCHEM.COMPOUND:2269

object_name: Bronchospasm


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEMBL.COMPOUND:CHEMBL2108015

subject_name: VITAMIN B COMPLEX

object_name: Postoperative Pain, Acute


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:9316

subject_name: Sufentanil

object_name: Sedation


subject: CHEBI:9316

object_name: Sedated


subject: UMLS:C0242896

subject_name: Anticholinergic Agents

object_name: Female sexual dysfunction


subject: UMLS:C3537004

subject_name: Anticholinergic [EPC]


subject: PUBCHEM.COMPOUND:156501355

object_name: small cell lung carcinoma


subject: MESH:C097428

subject_name: Bioseal

object_name: congenital vascular malformation


subject: MESH:C097428

object_name: vascular malformation


subject: MESH:C097428

object_name: cancer


subject: MESH:C097428

object_name: benign neoplasm


subject: UMLS:C3653474

subject_name: Corticosteroids acting locally

object_name: alopecia areata


subject: UMLS:C3653474

object_name: alopecia


subject: UMLS:C1522385

subject_name: Recombinant Gonadotropin

object_name: paroxysmal familial ventricular fibrillation


subject: UMLS:C1522385

object_name: ventricular fibrillation, paroxysmal familial, type 1


subject: UMLS:C1522385

object_name: uterine fibroid


subject: UMLS:C0018061

subject_name: Gonadotropins


subject: UMLS:C0018061


subject: UMLS:C0018061


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: Mechanical ventilation finding


subject: UNII:ZX1I49XP7L

object_name: plasma cell myeloma


subject: UMLS:C4329315

subject_name: Anti-CD352 Antibody-drug Conjugate SGN-CD352A


subject: UNII:3Z30JH9QX1

object_name: hepatitis C


subject: GTOPDB:12990

subject_name: sintilimab

object_name: liver neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Neuroendocrine carcinoma of the bladder


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA